Lipum
Manufacturing · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Tvistevägen 48c, Umea, Vaesterbotten, 90...Phone Number
+46 903403430Website
www.lipum.seRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Lipum
Lipum is a biopharmaceutical company focused on developing a first-in-class anti-inflammatory drug, SOL-116, aimed at treating chronic inflammatory diseases such as rheumatoid arthritis. The company has completed a Phase 1 clinical study for SOL-116, which demonstrated its potential to alleviate symptoms and improve the quality of life for millions affected by these conditions. Lipum's innovative approach seeks to provide a unique mechanism of action in the treatment landscape for chronic inflammatory diseases. Their intended clients include patients suffering from rheumatoid arthritis and other inflammatory diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lipum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Lipum had a recent Job posting/layoffs
Product Launch: Get notified when Lipum launches new products
Check out if Lipum is spiking on competitors!
Lipum, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Lipum
Check if Lipum has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Lipum has new funding data
Earning: See what the market has to say on Lipum recently announced quarterly report
Recommended Actions
Find VP level buyers at Lipum
Find more new buyers
Company Profile Activity
Activity Insights
Lipum is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lipum is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lipum.
Lipum Tech Stack
A closer look at the technologies used by Lipum
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
New Hire
Executive Move
New Hire
Executive Move
Lipum News & Media
Chairman on Lipum's progress, vision, and challenges - BioStock
Interview with Lipum's Chairman Ingemar Kihlström regarding his background and vision for the drug development project SOL-116Lipum recruits new CMO: "I have been following their research for a while and am impressed"
Lipum has strengthened its management team by appointing Peter Hovstadius as the new Chief Medical Officer.BioStock: Ola Sandborgh takes over as CEO of Lipum
Lipum has appointed Ola Sandborgh as their new CEO, effective from December 1, 2023. With over 30 years of experience in the pharmaceutical industry, he takes over the helm from current CEO Einar Pontén, who will remain in the company in a new role focused on business development. BioStock had the opportunity to interview both Sandborgh and Pontén about the upcoming CEO change and the company’s development plans. Read the full article at biostock.se: https://www.biostock.se/en/2023/11/ola-sandboLipum appoints Ola Sandborgh as new Chief Executive Officer - MarketScreener
Lipum , a clinical stage biopharmaceutical company focused on chronic inflammatory diseases, today announced that the Board of Directors has appointed Ola Sandborgh as new Chief Executive Officer,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lipum
Sign Up For FreeTo access detailed company insights
Lipum is a biopharmaceutical company focused on developing a first-in-class anti-inflammatory drug, SOL-116, aimed at treating chronic inflammatory diseases such as rheumatoid arthritis. The company has completed a Phase 1 clinical study for SOL-116, which demonstrated its potential to alleviate symptoms and improve the quality of life for millions... Read More
